MedTrace Logo

The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

NCT00436059 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-07-08

No results posted yet for this study

Summary

The primary objective of the the study is to investigate the changes in bone remodeling during Velcade treatment.

Conditions

Interventions

DRUG

bortezomib

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Torben Plesner, MD · Vejle Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00436059 on ClinicalTrials.gov